Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
University of Pittsburgh Merck |
---|---|
Information provided by: | University of Pittsburgh |
ClinicalTrials.gov Identifier: | NCT00360282 |
The purpose of this study is to determine if Rizatriptan, a migraine medication, lowers motion sickness in migraine sufferers.
Condition | Intervention | Phase |
---|---|---|
Migraine |
Drug: Rizatriptan Other: Placebo |
Phase 0 |
Study Type: | Interventional |
Study Design: | Prevention, Randomized, Double Blind (Subject, Investigator), Placebo Control, Crossover Assignment, Efficacy Study |
Official Title: | Effect of Rizatriptan on Rotational Motion Sickness in Migraineurs |
Estimated Enrollment: | 25 |
Study Start Date: | August 2006 |
Estimated Study Completion Date: | January 2009 |
Estimated Primary Completion Date: | October 2008 (Final data collection date for primary outcome measure) |
Migraine sufferers undergo vestibular tests to note abnormalities. There are 2 experimental visits in which migraine sufferers are given either the Rizatriptan or a fake pill and then are asked to rotate in a chair that is tilted. Motion sickness scores are taken throughout testing.
Ages Eligible for Study: | 21 Years to 45 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Susan Strelinski | (412) 647-8088 | strelinskisb@upmc.edu |
Contact: Anita Lieb, MS, CCRC | (412) 647-8087 | alieb@pitt.edu |
United States, Pennsylvania | |
University of Pittsburgh | Recruiting |
Pittsburgh, Pennsylvania, United States, 15213 | |
Principal Investigator: Joseph M Furman, MD, PhD | |
Sub-Investigator: Dawn Marcus, MD |
Principal Investigator: | Joseph M Furman, MD, PhD | University of Pittsburgh |
Responsible Party: | University of Pittsburgh ( Dr. Joseph Furman ) |
Study ID Numbers: | 0602009, Merck31449 |
Study First Received: | August 2, 2006 |
Last Updated: | October 10, 2008 |
ClinicalTrials.gov Identifier: | NCT00360282 |
Health Authority: | United States: Institutional Review Board |
Migraine Vertigo Motion Sickness |
Migraine Disorders Headache Central Nervous System Diseases Disorders of Environmental Origin Headache Disorders, Primary Rizatriptan |
Motion Sickness Brain Diseases Serotonin Vertigo Headache Disorders |
Serotonin Agonists Neurotransmitter Agents Serotonin Agents Molecular Mechanisms of Pharmacological Action |
Physiological Effects of Drugs Nervous System Diseases Pharmacologic Actions |